← Back
Chiron Real Estate
XRN · listed on the New York Stock Exchange · worth $439.76 million
$30.17
−1.15% on Oct 30
Eight insider buys in the last year, $2.58 million in all. None in the last two weeks.
Green dot = an insider bought◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
12.2M shares
92% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, four insiders bought Chiron Real Estate stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Director
Charles Fitzgerald
Bought $991.9K on Aug 10 — 27,600 shares at $35.94, held through a trust or family, 22% of what they now own.
No earlier purchases to measure
COO
Aaron Robert Roseth
Bought $495.9K on Aug 12 — 13,500 shares at $36.73, 100% of what they now own.
First purchase we have on file
CEO and President
Mark Okey Decker Jr
Bought $287K on Aug 10 — 8,000 shares at $35.88, 12% of what they now own.
0 of 1 earlier purchase did better than the S&P 500
Big investors
People and funds that reported owning 5% or more of Chiron Real Estate, newest first.
Filed by someone who owns 5% or more and does not plan to influence the company. · updateVanguard Portfolio Management LLC4.8%Oct 30Reported stake, oldest first: 5.0% (Jul 31) → 4.8% (Oct 30)
Filed by someone who owns 5% or more and does not plan to influence the company.Vanguard Portfolio Management LLC5.0%Jul 31
Each history starts at the oldest report we hold.
All reports
Every insider trade and SEC report we hold for Chiron Real Estate.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Aug 17BoughtMatthew Fitzsimmons WhitlockAug 17 · Traded Aug 14 · Chief Investment Officer+33%500 @ $37.21$18.6K
3 more with Pro →Analysts, earnings and news
Analysts' price target
$38.00 average
8 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
0 of 4 quarters above
Q2 '26−$0.65 a share−$0.25
Q1 '26−$0.06 a share−$0.07
Q4 '25−$0.02 a share−$0.15
Q3 '25$0.01 a share−$0.03